Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Vitiligo and alopecia areata may have similar causes despite their differences.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

Alopecia areata and psoriasis vulgaris can inhibit each other in the same areas.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

A rare form of lupus caused hair loss and skin bumps, diagnosed through biopsy, improved partially with treatment.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

People with autism are more likely to develop alopecia areata than those without autism.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Targeting specific T cells may help treat alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.